Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Infection, Response to Therapy of”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01683786
What this trial is testing

36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8

Who this might be right for
Hepatitis C Infection
Chang Gung Memorial Hospital 60
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Testing effectiveness (Phase 2)Study completedNCT00517439
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 516
Testing effectiveness (Phase 2)UnknownNCT01025297
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone

Who this might be right for
Hepatitis C
Cytheris SA 18
Large-scale testing (Phase 3)Study completedNCT01542788
What this trial is testing

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 278
Early research (Phase 1)Study completedNCT00718172
What this trial is testing

Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 81
Testing effectiveness (Phase 2)Study completedNCT04596475
What this trial is testing

Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor

Who this might be right for
Hepatitis CHepatitis C Virus Infection, Response to Therapy of
University of California, San Diego 12
Testing effectiveness (Phase 2)Ended earlyNCT00840489
What this trial is testing

Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis

Who this might be right for
Chronic Hepatitis C
Hospital Universitario Ramon y Cajal 50
Post-approval studies (Phase 4)Study completedNCT02339038
What this trial is testing

Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia

Who this might be right for
HCV HIV
National Institutes of Health Clinical Center (CC) 600
Testing effectiveness (Phase 2)Study completedNCT00475176
What this trial is testing

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT03155113
What this trial is testing

Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliero-Universitaria di Parma 77
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Testing effectiveness (Phase 2)Study completedNCT00085917
What this trial is testing

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Large-scale testing (Phase 3)Study completedNCT00308048
What this trial is testing

14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response

Who this might be right for
Hepatitis C Virus Infection
Ullevaal University Hospital 435
Not applicableUnknownNCT05376943
What this trial is testing

Possible Differences in HCC Course Depending on DAA Treatment

Who this might be right for
Carcinoma, HepatocellularHepatitis C Virus Infection, Response to Therapy ofDrug Effect+3 more
Medical University of Warsaw 100
Post-approval studies (Phase 4)Study completedNCT00351403
What this trial is testing

Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
FGK Clinical Research GmbH 390
Large-scale testing (Phase 3)Study completedNCT00211692
What this trial is testing

Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

Who this might be right for
Chronic Hepatitis C
Minneapolis Veterans Affairs Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT01888900
What this trial is testing

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

Who this might be right for
CirrhosisChronic Hepatitis CHepatitis C+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 35
Large-scale testing (Phase 3)Study completedNCT02487030
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 255
Post-approval studies (Phase 4)Study completedNCT02339337
What this trial is testing

A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection

Who this might be right for
HBV/HCV Co-infection
Kaohsiung Medical University Chung-Ho Memorial Hospital 203
Next Page